Umeclidinium/vilanterol

Details

Files

Generic Name:

Umeclidinium/vilanterol

Project Status:

Complete

Therapeutic Area:

Chronic obstructive pulmonary disease

Manufacturer:

GlaxoSmithKline Inc.

Call for patient/clinician input open:

July 9, 2014

Brand Name:

Anoro Ellipta

Project Line:

Reimbursement Review

Project Number:

SR0371-000

Call for patient/clinician input closed:

August 28, 2014

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Chronic Obstructive Pulmonary Disease

Recommendation Type:

List with criteria/condition

Final Recommendation:

January 15, 2015

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Patient Group Input Submissions View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Last Updated : February 26, 2014